HI
XBI icon

Hudock Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hudock Inc’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-944
Closed -$74K – 764
2022
Q3 		$74K Sell
944
-1,272
-57% -$107K 0.03% 242
2022
Q2 		$164K Buy
2,216
+901
+69% +$67.6K 0.05% 156
2022
Q1 		$118K Buy
1,315
+70
+6% +$6.46K 0.03% 208
2021
Q4 		$139K Buy
1,245
+28
+2% +$3.38K 0.04% 202
2021
Q3 		$153K Hold
1,217
– – 0.05% 178
2021
Q2 		$164K Buy
1,217
+379
+45% +$49.8K 0.05% 170
2021
Q1 		$113K Hold
838
– – 0.04% 214
2020
Q4 		$118K Buy
838
+301
+56% +$38.6K 0.04% 193
2020
Q3 		$59K Sell
537
-100
-16% -$11.2K 0.02% 255
2020
Q2 		$71K Hold
637
– – 0.03% 220
2020
Q1 		$49K Sell
637
-1,098
-63% -$97.2K 0.02% 227
2019
Q4 		$164K Hold
1,735
– – 0.05% 123
2019
Q3 		$132K Hold
1,735
– – 0.05% 136
2019
Q2 		$152K Hold
1,735
– – 0.06% 122
2019
Q1 		$157K Buy
+1,735
New +$148K 0.06% 127
2018
Q4 		– Sell
-551
Closed -$52K – 712
2018
Q3 		$52K Sell
551
-5
-0.9% -$485 0.02% 239
2018
Q2 		$52K Buy
556
+34
+7% +$3.13K 0.02% 223
2018
Q1 		$45K Buy
522
+489
+1,482% +$44.6K 0.02% 250
2017
Q4 		$2K Buy
+33
New +$2.77K ﹤0.01% 588
2015
Q4 		– Sell
-41
Closed -$2K – 599
2015
Q3 		$2K Sell
41
-19
-32% -$1.5K ﹤0.01% 530
2015
Q2 		$5K Hold
60
– – ﹤0.01% 474
2015
Q1 		$5K Hold
60
– – ﹤0.01% 494
2014
Q4 		$4K Hold
60
– – ﹤0.01% 461
2014
Q3 		$3K Hold
60
– – ﹤0.01% 506
2014
Q2 		$3K Hold
60
– – ﹤0.01% 523
2014
Q1 		$3K Hold
60
– – ﹤0.01% 502
2013
Q4 		$3K Hold
60
– – ﹤0.01% 505
2013
Q3 		$3K Hold
60
– – ﹤0.01% 448
2013
Q2 		$2K Buy
+60
New +$2.11K ﹤0.01% 475

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Hudock Inc's XBI Position: Q4 2022 in Review

Hudock Inc sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2022, closing a stake of 944 shares — an estimated $74K sold.

Hudock Inc first reported a position in XBI in Q2 2013 and held it in 29 quarters. The position peaked at $164K in Q2 2022. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

  • Hudock Inc reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 944 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $74K.
  • Hudock Inc first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 29 quarters.
  • Hudock Inc's State Street SPDR S&P Biotech ETF position peaked at $164K in Q2 2022.
  • 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.